[Ca2+] i reduction of CaV2 1 alpha 1 gene mutation mice in in-vitro ischemia model
A technology of α1 subunit and model, applied in the field of biomedicine, can solve problems of different severity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0038] Expression pattern of Cav2.1α1 mRNA
[0039] We used in situ hybridization to evaluate the distribution of Cav2.1α1 mRNA in wild-type mice (n=6), rollingNagoya (n=5) and leanermice (n=5); the distribution in the three mice was the same (Data not shown). We detected a widespread expression of α1 subunit in the brains of these three mice using antisense probes, especially in olfactory bulb neurons, cerebral cortex neurons, hippocampus neurons and cerebellum neurons There are strong expressions. However, no signal was detected after using the sense probe. We used real-timeqRT-PCR to detect the expression levels of CaV2.1α1mRNA in the olfactory bulb, cerebral cortex, caudate putamen, hippocampus, cerebellum and liver in these three mice. In the olfactory bulb, cerebral cortex, caudate putamen, hippocampus, and cerebellum of these three mice, the relative expression levels of total CaV2.1α1 were not significantly different (wild-type mice, rolling Nagoya and leaner mice i...
Embodiment 2
[0041] CaV2.1α1 mutant mice have reduced infarct volume in an in vivo ischemia model
[0042]Wild-type mice (n=12), rollingNagoya (n=11) and leanermice (n=12) were treated with middle cerebral artery occlusion. We distinguish cerebral infarction from the color, which is a white unstained area surrounded by red living tissue. Fig.1A is a set of representative experimental results, which are the results obtained after staining for 24 hours after the infarct was permanently occluded with TTC. After treatment with middle cerebral artery occlusion, the infarct area was significantly different in the three mice. The proportion of the infarct region to the total brain volume was 27.1±3.5% in rollingNagoya, 20.2±3.5% in leanermice, and 42.9±4.5% in wild-type mice.
Embodiment 3
[0044] CaV2.1α1 gene mutant mice in in vitro ischemia model [Ca 2+ ]i reduction
[0045] To investigate whether the reduction in infarct volume in mutant mice is related to the neuronal calcium pathway, we used hippocampal slices to examine [Ca 2+ ]i changes, OGD treatment can make local ischemia. Ca V The 2.1 channel is strongly expressed in the hippocampus. Before OGD treatment, there was no significant difference in the basal ratio of the pyramidal cell layer in the CA1 region among the three mice (wild type: 0.847±0.011; rollingNagoya: 0.827±0.022; leanermice: 0.803±0.013). Once OGD starts processing, [Ca 2+ ]i appeared increasing, and within 4 minutes after treatment, the normalized index of wild-type mice was much higher than that of the other two groups of mice. The maximum rate of increase was also different among the three mice. The rate of increase was 0.083±0.007 / min (p<0.01) in rollingNagoya, 0.062±0.006 / min (p<0.01) in leanermice, and 0.105±0.008 / min in wild...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com